ArticleJournal of inflammation research2026
Screening and Targeting the HMGB1/RAGE Axis via Proteomics to Alleviate Inflammatory Responses in a
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Ventilator-associated pneumonia (VAP) is a common and serious complication in mechanically ventilated patients, with Methods: Quantitative proteomics was employed to analyze protein expression changes in a PA-induced rat model of VAP. Bioinformatics analysis was performed to identify key signaling pathways and potential small-molecule inhibitors. Immuno-infiltration analysis and immunofluorescence co-localization assays were conducted on rat lung tissues. The expression levels of HMGB1, RAGE, TNF-α, IL-1β, and IL-6 in bronchoalveolar lavage fluid (BALF) and blood were measured using ELISA. Results: PA infection induced the upregulation of the HMGB1/RAGE axis. Bioinformatics analysis indicated that the HMGB1/RAGE axis is involved in key pathways such as neutrophil extracellular trap (NET) formation and identified potential small-molecule inhibitors, including potassium nitrate and 2-mercaptoethanol. Immuno-infiltration analysis revealed a negative correlation between the HMGB1/RAGE axis and monocytes. FPS-ZM1-treated rats showed reduced co-expression of HMGB1 and RAGE in lung tissue, decreased levels of HMGB1, RAGE, TNF-α, IL-1β, and IL-6 in BALF and blood, and attenuated systemic inflammatory responses. Conclusion: These results suggest that the HMGB1/RAGE axis is associated with the inflammatory response in a PA-induced rat model of VAP, and that blocking this interaction with FPS-ZM1 alleviates both lung injury and systemic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.